Maha Ayyoub

T2i :

Anti-tumour immunity and immunotherapy

The specificities
of our research axis

Tumour antigen-specific T cells

T cell depletion

Immune checkpoint inhibitor immunotherapy

Anti-cancer vaccines

Clinical trials

Pre-clinical orthotopic models




Scientific production

Cerapio, Juan-Pablo, Marion Perrier, Camille-Charlotte Balança, Pauline Gravelle, Fréderic Pont, Christel Devaud, Don-Marc Franchini, et al. “Phased Differentiation of Γδ T and T CD8 Tumor-Infiltrating Lymphocytes Revealed by Single-Cell Transcriptomics of Human Cancers.” Oncoimmunology 10, no. 1 (2021): 1939518.
Khalifa, Jonathan, Julien Mazieres, Carlos Gomez-Roca, Maha Ayyoub, and Elizabeth Cohen-Jonathan Moyal. “Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?” Frontiers in Oncology 11 (2021): 662236.
Balança, Camille-Charlotte, Anna Salvioni, Clara-Maria Scarlata, Marie Michelas, Carlos Martinez-Gomez, Carlos Gomez-Roca, Victor Sarradin, et al. “PD-1 Blockade Restores Helper Activity of Tumor-Infiltrating Exhausted PD-1hiCD39+ CD4 T Cells.” JCI Insight, December 17, 2020.
Montfort, Anne, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès, Cécile Pages, Pascale Olivier, et al. “Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase 1b Clinical Trial.” Clinical Cancer Research, December 3, 2020, clincanres.3449.2020.
Weulersse, Marianne, Assia Asrir, Andrea C. Pichler, Lea Lemaitre, Matthias Braun, Nadege Carrie, Marie-Veronique Joubert, et al. “Eomes-Dependent Loss of the Co-Activating Receptor CD226 Restrains CD8(+) T Cell Anti-Tumor Functions and Limits the Efficacy of Cancer Immunotherapy.” Immunity 53, no. 4 (October 13, 2020): 824-839.e10.
Fluckiger, Aurélie, Romain Daillère, Mohamed Sassi, Barbara Susanne Sixt, Peng Liu, Friedemann Loos, Corentin Richard, et al. “Cross-Reactivity between Tumor MHC Class I-Restricted Antigens and an Enterococcal Bacteriophage.” Science (New York, N.Y.) 369, no. 6506 (August 21, 2020): 936–42.
Trimaglio, Giulia, Anne-Françoise Tilkin-Mariamé, Virginie Feliu, Françoise Lauzéral-Vizcaino, Marie Tosolini, Carine Valle, Maha Ayyoub, et al. “Colon-Specific Immune Microenvironment Regulates Cancer Progression versus Rejection.” Oncoimmunology 9, no. 1 (July 12, 2020): 1790125.
Martinez, Alejandra, Jean-Pierre Delord, Maha Ayyoub, and Christel Devaud. “Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer.” Cancers 12, no. 7 (July 2, 2020): 1761.
Balança, Camille-Charlotte, Clara-Maria Scarlata, Marie Michelas, Christel Devaud, Victor Sarradin, Camille Franchet, Carlos Martinez Gomez, et al. “Dual Relief of T-Lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies.” Cancer Immunology Research 8, no. 7 (July 2020): 869–82.
Pont, Frédéric, Marie Tosolini, Qing Gao, Marion Perrier, Miguel Madrid-Mencía, Tse Shun Huang, Pierre Neuvial, Maha Ayyoub, Kristopher Nazor, and Jean-Jacques Fournié. “Single-Cell Virtual Cytometer Allows User-Friendly and Versatile Analysis and Visualization of Multimodal Single Cell RNAseq Datasets.” NAR Genomics and Bioinformatics 2, no. 2 (June 1, 2020): lqaa025.
Prat, Mélissa, Augustin Le Naour, Kimberley Coulson, Fanny Lemée, Hélène Leray, Godefroy Jacquemin, Mouna Chirine Rahabi, et al. “Circulating CD14 high CD16 low Intermediate Blood Monocytes as a Biomarker of Ascites Immune Status and Ovarian Cancer Progression.” Journal for ImmunoTherapy of Cancer 8, no. 1 (2020): e000472.
Montfort, Anne, Carine Dufau, Céline Colacios, Nathalie Andrieu-Abadie, Thierry Levade, Thomas Filleron, Jean-Pierre Delord, Maha Ayyoub, Nicolas Meyer, and Bruno Ségui. “Anti-TNF, a Magic Bullet in Cancer Immunotherapy?” Journal for Immunotherapy of Cancer 7, no. 1 (November 14, 2019): 303.
Franchini, Don-Marc, Olivia Lanvin, Marie Tosolini, Emilie Patras de Campaigno, Anne Cammas, Sarah Péricart, Clara-Maria Scarlata, et al. “Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells.” Cell Reports 26, no. 1 (January 2, 2019): 94-107.e7.


Mathieu Ajalbert
Ingénieur ou technicien / Engineer or Technician
Myriam Maixent
Ingénieur ou technicien / Engineer or Technician
Carlos Gomez-Roca
Personnel hospitalier / Hospital Staff
Maha Ayyoub
Enseignant-chercheur / Teacher-researcher
Françoise Lauzeral-Vizcaino
Ingénieur ou technicien / Engineer or Technician
Clara-Maria Scarlata
Ingénieur ou technicien / Engineer or Technician
Anna Salvioni
Chercheur / Researcher
Christel Devaud
Chercheur / Researcher
Victor Sarradin
Etudiant ou stagiaire / PhD student or Trainee
Giulia Costanza Leonardi
Chercheur / Researcher
Virginie Feliu
Ingénieur ou technicien / Engineer or Technician
Lise Scandella
Ingénieur ou technicien / Engineer or Technician
Marie Michelas
Ingénieur ou technicien / Engineer or Technician
Célia Ramade
Etudiant ou stagiaire / PhD student or Trainee
Sylvie Giuriato
Chercheur / Researcher
Noémie Thébault
Ingénieur ou technicien / Engineer or Technician

Partnerships & Funding

Centre de Recherches en Cancérologie de Toulouse

Centre de Recherches en Cancérologie de Toulouse (Oncopole)

Toulouse – FR

Nous contacter

05 82 74 15 75

Envie de rejoindre
L’équipe du CRCT ?

Pin It on Pinterest